BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,198,132 | +56.9% | 111,312 | +82.3% | 0.02% | -13.6% |
| Q4 2021 | $8,413,000 | +15.6% | 61,047 | +16.5% | 0.02% | +10.0% |
| Q3 2021 | $7,278,000 | -10.6% | 52,391 | -37.5% | 0.02% | +66.7% |
| Q2 2021 | $8,142,000 | +164.0% | 83,862 | +85.9% | 0.01% | +33.3% |
| Q1 2021 | $3,084,000 | -18.8% | 45,116 | +1.9% | 0.01% | -25.0% |
| Q4 2020 | $3,797,000 | -14.2% | 44,295 | -35.0% | 0.01% | -25.0% |
| Q3 2020 | $4,427,000 | -56.0% | 68,104 | -50.5% | 0.02% | -20.0% |
| Q2 2020 | $10,054,000 | +128.6% | 137,522 | +6.4% | 0.02% | +81.8% |
| Q1 2020 | $4,398,000 | +24.9% | 129,226 | -1.0% | 0.01% | -21.4% |
| Q4 2017 | $3,520,000 | – | 130,484 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |